Exploring Functionally Enhanced BLP‐Trained Macrophage Subpopulations in <i>S. Aureus</i> Infection: Underlying Mechanisms and Therapeutic Significance
Tolerance to bacterial lipoprotein (BLP) is an evolved protective mechanism characterized by an enhanced resistance of BLP-trained macrophages to microbial infection. However, the underlying mechanisms are not fully understood, and their potential for translational clinical application needs further evaluation. In the present study, through single-cell RNA sequencing (scRNA-seq), transcriptomic profiles in both naïve and BLP-trained bone marrow-derived macrophages (BMDMs) during Staphylococcus aureus infection are analyzed, and 13 distinct BMDM subpopulations are identified. Notably, BLP-trained tolerance initiates the emergence of two novel BMDM subpopulations, C5 and C7, characterized by increased antibacterial gene expression and enhanced anti-inflammatory and antioxidative stress abilities. Moreover, BLP-trained BMDMs demonstrate activation of the NRF2 signaling pathway, thereby augmenting an antioxidative stress response and mitigating oxidative stress-induced cell damage and ferroptosis, while undergoing metabolic reprogramming characterized by enhanced glycolysis and oxidative phosphorylation pathways, together with increased anti-inflammatory metabolites. Critically, in vivo adoptive transfer of BLP-trained BMDMs protects mice against sepsis-associated lethality by attenuating systemic inflammatory response, accelerating bacterial clearance, and alleviating organ damage. Collectively, the present study presents a single-cell atlas of murine BMDMs at rest and under S. aureus infection following BLP training, which reveals novel mechanisms of BLP training-altered macrophage immunity and identifies macrophage subpopulations responsible for an enhanced resistance to infection, thus offering new preventive and therapeutic strategies for sepsis.
Authors
- Yantong Wan
- Yong Jiang (ORCID: https://orcid.org/0000-0002-8087-5717)
- Huaping Liang (ORCID: https://orcid.org/0000-0003-4157-445X)
- Tengfei Xu (ORCID: https://orcid.org/0000-0002-6361-6895)
- Yinghao Hong
- Tieliu Shi (ORCID: https://orcid.org/0000-0001-5592-2836)
- Jing Xiang (ORCID: https://orcid.org/0000-0002-2977-1410)
- Meng Ren
- Zhijie Li (ORCID: https://orcid.org/0000-0002-3186-144X)
- Jinghua Liu
- Wenhan Chen (ORCID: https://orcid.org/0000-0002-5833-0008)
- Lixin Liang
- Xiangjun Ji (ORCID: https://orcid.org/0000-0002-9467-0173)
- Jinxi Liu
Institutions
- Army Medical University (CN)
- Jinan University (CN)
- Third Affiliated Hospital of Southern Medical University (CN)
- Daping Hospital (CN)
- Shenzhen Second People's Hospital (CN)
- Southern Medical University (CN)
- East China Normal University (CN)
Publication Details
- Journal
- Advanced Science
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1002/advs.202417142
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University College Cork
- National Natural Science Foundation of China
- Chongqing Medical University
- Southern Medical University
- Basic and Applied Basic Research Foundation of Guangdong Province